Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
531 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-05)
Due Date
January 05, 2027
Grace Period Ends
July 05, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 5, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 2, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Dec 1, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Dec 1, 2020 | ISSR | Z | WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST | Loading... |
| Dec 1, 2020 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Dec 1, 2020 | SNEA | W | SU-EXAMINER'S AMENDMENT WRITTEN | Loading... |
| Dec 1, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 1, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 30, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 14, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 14, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 2, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 2, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 23, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 28, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 28, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 8, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 23, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 16, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 16, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 16, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 16, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 16, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 13, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 18, 2019 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 17, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Dec 17, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations featuring antisense oligonucleotides, for the treatment of neuromuscular diseases and disorders
First Use Anywhere:
Dec 12, 2019
First Use in Commerce:
Dec 12, 2019
Additional Information
Design Mark
The mark consists of a hexagon, bisected by a swoosh, followed by the text and numeral "VYONDYS 53" over the text "(golodirsen) Injection"; the color gray is intended to show shading or contrast only.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "VYONDYS" has no meaning in a foreign language.
Pseudo Mark
VYONDYS FIFTY THREE (GOLODIRSEN) INJECTION; VYONDYS FIVE THREE (GOLODIRSEN) INJECTION
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"53 (GOLODIRSEN) INJECTION"